The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Factors such as growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to …
0 
0 
0 
0 
The post Bioburden Testing Market – An Emerging Market with Attractive Growth Opportunities appeared first on MarketsandMarkets Blog.